July 23, 2019 10:59 AM EDT
News Briefing

Pro­teosta­sis shakes up med­ical team; No­vo funds an­tibi­otics ef­forts out of Curza, Spero

Amber Tong

→ Po-Shun Lee is hit­ting the ex­it at Pro­teosta­sis Ther­a­peu­tics, trig­ger­ing a pro­mo­tion for Ge­of­frey Gilmartin to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

No­vo Nordisk is feel­ing the com­pe­ti­tion from com­pound­ed GLP-1s, ex­ec says

Small per­son­al­ized vac­cine tri­al sees progress in late-stage kid­ney can­cer

GSK de­fi­ant against vac­cine chal­lenges, will pri­or­i­tize oth­er growth ar­eas

Am­gen an­nounces hold on Phase 1 obe­si­ty can­di­date, pipeline cuts

Ku­ra's AML drug pass­es key study in ad­vanced pa­tients, plans next steps with FDA and new­ly di­ag­nosed stud­ies

Pfiz­er says it has at least $10B avail­able for deals in 2025, with a fo­cus on pipeline

A service from the Financial Times